Channel: Dr. John Campbell

Category: Education

Tags: human biologydiseasebiologymedical educationphysiologyhealthnursingmedicinehuman bodycampbellnclexpathophysiologynurse education

Description: Symptomatic cases, UK covid.joinzoe.com/data youtube.com/watch?v=8JqdsQcvgL8 covid.joinzoe.com/post/covid-numbers-tumble Down 27 % on the week Government figures 10 times lower UK R-value = 0.8 England, 0.8 Wales, 0.9 Scotland, 0.9. One in 27 people in the UK currently symptomatic BA.1 BA.2 symptoms BA.2 probably generate more mild symptoms BA.2 lower severity XE, not currently a big concern ONS ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavetestedpositiveforcovid19uk/22april2022 Cumulative percentage, tested positive, survey N = 535,116 27th April 2020 to 11th February 2022 70.7% in England (38.5 million people) 56.0% in Wales (1.7 million people) 72.2% in Northern Ireland (1.3 million people) 51.5% in Scotland (2.7 million people) Risk of reinfection 10 times higher in Omicron times (20 December 2021 to 20 March 2022) Compared with the period when the Delta variant was most common (17 May to 19 December 2021). Risk of death Risk of death involving Omicron variant was 67% lower than the Delta variant of COVID-19 Antibodies Self-reported long COVID 1.8 million people (2.8% of the population) As of 3 April 2022 73% symptoms at least 12 weeks 44% at least one year Features Fatigue, 51% Shortness of breath, 33% Loss of sense of smell, 26% Difficulty concentrating, 23% Symptoms adversely affected the day-to-day activities, 67%) In double-vaccinated people Self-reported long COVID was almost twice as common after Delta than after Omicron BA.1 infections Antibody levels blog.ons.gov.uk/2021/04/28/antibodies-and-immunity-how-do-they-relate-to-one-another At or above the 179 ng/ml (16 and older) 98.8% in England 98.7% in Wales 99.0% in Northern Ireland 98.9% in Scotland Antibody level of 800 ng/ml 95.4% in England 95.6% in Wales 94.4% in Northern Ireland 94.7% in Scotland